文献速递乳房整形与再造创面修复

乳房再造术后切口闭合负压治疗的经济学分析

Economic Analysis Based on the Use of Closed-Incision Negative-Pressure Therapy after Postoperative Breast Reconstruction.
PubMed 文献 · Plast Reconstr Surg · 2019-01-01

该研究基于一项回顾性研究(665个乳房,356例患者)的临床结局,应用假设成本模型比较乳房即刻再造术后切口使用闭合切口负压治疗(ciNPT)与标准护理(SOC)的成本。调整后并发症平均成本为10,402美元,ciNPT组总并发症成本250,000美元,SOC组395,000美元,每例患者节省218美元。初步显示ciNPT可能节约成本,需进一步研究其成本效益。

要点

  • ciNPT组乳房水平并发症率8.5%(28/331),SOC组15.9%(53/334),P=0.0092。
  • 调整后并发症平均成本10,402美元,ciNPT组总成本250,000美元,SOC组395,000美元。
  • ciNPT每例患者节省218美元,提示潜在成本节约。

核心结论

  • 初步发现乳房切口使用ciNPT可能节约成本,需进一步研究其成本效益。

研究设计与样本

  • 基于既往回顾性研究临床结局的假设成本模型,纳入665个乳房(ciNPT=331,SOC=334)和356例女性患者(ciNPT=177,SOC=179)。
  • 调整后并发症成本使用住院、门诊和承运人索赔数据库计算,乳房切除加再造的平均并发症成本为10,402美元。

主要发现

  • 乳房水平并发症率ciNPT组8.5%(28/331),SOC组15.9%(53/334),P=0.0092。
  • 患者水平并发症:ciNPT组24/177(13.6%),SOC组38/179(21.2%)。
  • 基于调整后平均并发症成本10,402美元,ciNPT组总并发症成本250,000美元,SOC组395,000美元,每例患者节省218美元。

临床怎么用

  • 在乳房即刻再造术后切口考虑使用ciNPT可能降低并发症相关成本。

局限性

  • 作者称其为初步发现,需进一步研究ciNPT与标准护理的成本效益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Breast cancer accounts for 30% of all new cancer diagnoses in women. Although more options are now available regarding breast reconstruction, the risk of complications (eg, infection, dehiscence, and expander exposure) is also prevalent and must be considered when choosing a reconstruction option because the cost for complications can be substantial. METHODS: A hypothetical cost model was applied to clinical outcomes of a previous retrospective study comparing the use of closed-incision negative-pressure therapy (ciNPT) and standard of care (SOC) over breast incisions after immediate reconstruction. The adjusted complication cost for a mastectomy with reconstruction was a mean of $10,402 and was calculated using a database of inpatient, outpatient, and carrier claims. RESULTS: The previous retrospective study included data on 665 breasts (ciNPT = 331, SOC = 334) and 356 female patients (ciNPT = 177, SOC = 179) and reported on complication rates at the breast level: 8.5% (28/331) for the ciNPT breast group versus 15.9% (53/334) for the SOC group (P = 0.0092). In the ciNPT group, 24/177 patients (13.6%) had a complication, whereas in the SOC group, 38/179 patients (21.2%) had a complication. Based on the adjusted mean complication cost of $10,402, total complication cost for the ciNPT group was $250,000 versus $395,000 for the SOC group with a per-patient cost savings of $218.00 with ciNPT. CONCLUSION: The authors' preliminary findings show potential cost savings with the use of ciNPT over breast incisions and warrant further study regarding the cost-effectiveness of ciNPT compared with standard of care after immediate breast reconstruction.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Gabriel A, Maxwell GP. Economic Analysis Based on the Use of Closed-Incision Negative-Pressure Therapy after Postoperative Breast Reconstruction. Plast Reconstr Surg. 2019. PMID: 30586102. doi:10.1097/PRS.0000000000005311

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。